https://tlh.prisysbiotech.com/ Ekki - Mannlegur Prímat Rannsóknir Pallur & CRO | PRISYS Líftækni https://tlh.prisysbiotech.com/uploads/39406/logo.png https://tlh.prisysbiotech.com/nhp-pharmacology/ NHP lyfjafræði https://tlh.prisysbiotech.com/uploads/39406/list/n20240227154733ebf63.jpg https://tlh.prisysbiotech.com/safety-evaluation/ Öryggismat https://tlh.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://tlh.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://tlh.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://tlh.prisysbiotech.com/translation-research/ Þýðingarannsóknir https://tlh.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://tlh.prisysbiotech.com/biosafety-research/ Rannsóknir á líföryggi https://tlh.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://tlh.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://tlh.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://tlh.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://tlh.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://tlh.prisysbiotech.com/uploads/39406/page/small/what-is-a-nhp-study0fe0f.jpg What Is A NHP Study https://tlh.prisysbiotech.com/uploads/39406/page/what-is-a-nhp-study0fe0f.jpg https://tlh.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://tlh.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg Toxicokinetics https://tlh.prisysbiotech.com/uploads/39406/toxicokinetics70843.jpg https://tlh.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://tlh.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-teste7c22.jpg Dose Range Finding Test https://tlh.prisysbiotech.com/uploads/39406/page/dose-range-finding-teste7c22.jpg https://tlh.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://tlh.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://tlh.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://tlh.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://tlh.prisysbiotech.com/uploads/39406/page/small/pharmacokineticsa44cd.jpg Pharmacokinetics https://tlh.prisysbiotech.com/uploads/39406/page/pharmacokineticsa44cd.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://tlh.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://tlh.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://tlh.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://tlh.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://tlh.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://tlh.prisysbiotech.com/pk-pd-adme/adme.html ADME https://tlh.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://tlh.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://tlh.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://tlh.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://tlh.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://tlh.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://tlh.prisysbiotech.com/uploads/202339406/small/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg Translational Studies https://tlh.prisysbiotech.com/uploads/202339406/translational-studiesd565144e-fcec-4437-afeb-42982ae7bab9.jpg https://tlh.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://tlh.prisysbiotech.com/uploads/202339406/small/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg New And Modified Applications https://tlh.prisysbiotech.com/uploads/202339406/new-and-modified-applicationsab01b425-decb-46a1-90d1-e5fee60f1327.jpg https://tlh.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity https://tlh.prisysbiotech.com/uploads/202339406/small/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg Immunotoxicity https://tlh.prisysbiotech.com/uploads/202339406/immunotoxicitya758bdcf-a01c-4970-a80d-758e345ae77f.jpg https://tlh.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://tlh.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://tlh.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://tlh.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://tlh.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://tlh.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://tlh.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://tlh.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://tlh.prisysbiotech.com/uploads/202339406/small/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg NHP Asthma/atopic Dermatitis Model https://tlh.prisysbiotech.com/uploads/202339406/nhp-asthma-atopic-dermatitis-model6bc15051-9b18-470b-a3ed-3a035fb26acc.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://tlh.prisysbiotech.com/uploads/202339406/small/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg NHP Non-Alcoholic Steatohepatitis (NASH) Model https://tlh.prisysbiotech.com/uploads/202339406/nhp-non-alcoholic-steatohepatitis-nash-model7332a6f4-bc77-45be-bf2b-07178c46a62a.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://tlh.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://tlh.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://tlh.prisysbiotech.com/uploads/202339406/small/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://tlh.prisysbiotech.com/uploads/202339406/nhp-chronic-obstructive-pulmonary-disease08000f1b-42f7-4c7d-9ba5-6f15c54993c9.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg Acute Myocardial Infarction/Heart Failure Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/acute-myocardial-infarction-heart-failure3d3bf8b7-5a0c-4f9d-8841-7f98a51cf834.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/pulmonary-artery-hypertension-embolism9d266a3e-e0d5-46d2-85d6-aad09f286515.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg Myopia Hyperopia Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/myopia-hyperopia-nhp-modela0553861-d7d5-4d4f-af65-68d25533d6ef.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg AMD Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/amd-nonhuman-primates-disease-modelf663a012-d546-4fbb-8d78-834cea736255.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg Glaucoma Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/glaucoma-nonhuman-primates-disease-model092df254-f018-4636-a429-8344948a9978.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg Uveitis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/uveitis-nonhuman-primates-disease-model0ba7fdbf-75a4-42f7-8990-e9daa0c176b0.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/small/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg Inflammatory Bowel Disease Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/inflammatory-bowel-nhp-disease-modelf4c414ff-a224-4634-a994-b8ba7a18a488.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://tlh.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://tlh.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg Neuropathic Pain Nonhuman Primates Disease Model https://tlh.prisysbiotech.com/uploads/202339406/neuropathic-pain-nhp-modela385dae9-a466-42bb-9982-13db42e0581b.jpg https://tlh.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://tlh.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://tlh.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://tlh.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://tlh.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://tlh.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://tlh.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://tlh.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://tlh.prisysbiotech.com/translation-research/clinical-imaging.html Klínísk myndgreining https://tlh.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klínísk myndgreining https://tlh.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://tlh.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://tlh.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://tlh.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://tlh.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://tlh.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://tlh.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Tegund 2 sykursýki líkan https://tlh.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Tegund 2 sykursýki líkan https://tlh.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://tlh.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://tlh.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://tlh.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://tlh.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://tlh.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://tlh.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://tlh.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://tlh.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://tlh.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://tlh.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://tlh.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://tlh.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://tlh.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://tlh.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://tlh.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://tlh.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://tlh.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://tlh.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://tlh.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://tlh.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://tlh.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://tlh.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://tlh.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://tlh.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://tlh.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://tlh.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://tlh.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://tlh.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://tlh.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://tlh.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://tlh.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://tlh.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://tlh.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://tlh.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://tlh.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://tlh.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://tlh.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://tlh.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://tlh.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://tlh.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://tlh.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://tlh.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://tlh.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://tlh.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://tlh.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17723920958448640.html 2025 Recap: Hvernig Prisys er að endurskilgreina þýðingaráreiðanleika í NHP rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://tlh.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551224544748544.html NHP - byggð lyfjafræði og lyfhrifþjónusta|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://tlh.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530069550654464.html Hittu Prisys líftækni á komandi vegasýningu ESB: september 2025 https://tlh.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17447468367946752.html Prisys Biotech-2025 um miðjan ár https://tlh.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://tlh.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17252000372286464.html Hittu Prisys í komandi bandarískum vegum í mars 2025 https://tlh.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://tlh.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84071469.html PRISYS ársskýrsla 2024: Framfarir NHP líkan og forklínískar rannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77716916.html Fréttabréf Prisys Biotech 2024 ársfjórðungi 2 https://tlh.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://tlh.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81209027.html Markviss meðferð við Parkinsonsveiki: Bylting í rauntíma segulómun-stýrðri stofnfrumuígræðslu https://tlh.prisysbiotech.com/uploads/39406/news/n202409061001122b75a.jpg https://tlh.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17723920999769088.html Þegar sársauki verður að minni: Tilfinningalegur drifkraftur langvarandi sársauka og kostur NHP líkansins|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://tlh.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17723920938230784.html Multi-Endapunktaverkjamat: Framtíð verkjalyfjaþróunar https://tlh.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://tlh.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17723921047168000.html Af hverju mistakast svo mörg verkjalyf í forklínískum rannsóknum? Svarið liggur í því hvernig við mælum sársauka https://tlh.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://tlh.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17723921373635584.html Hönnun blóðsýnatímapunkta í lyfjahvörfum (PK) rannsóknum|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://tlh.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17723921216840704.html PK tölfræði: Non-compartmental Analysis (NCA) færibreytur og forklínísk forrit https://tlh.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://tlh.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17723921021936640.html Hvers vegna ó-mannleg prímatlíkön eru mikilvæg fyrir miðtaugakirnismeðferðir https://tlh.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://tlh.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17723921051788288.html Umbrot þvagsýru hjá mönnum vs öpum: þýðingaráhrif fyrir lyfjaþróun https://tlh.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://tlh.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17723920862077952.html Non-Human Primate MASH-Tengd lifrartrefjunarlíkan|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://tlh.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17723921028178944.html Hvers vegna IMRI-Leiðbeinandi lyfjagjöf í heila er nauðsynleg fyrir nákvæma miðun í NHP rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://tlh.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17671557786461184.html Gervigreind-Drifið merkjalaust NHP 3D atferlisgreiningarkerfi|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://tlh.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17671557796160512.html LPS-Induced Acute Lung Inflammation (ALI) NHP líkan|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://tlh.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17671557874000896.html HDM+SEB-Atopic dermatitis (AtD) líkan í Cynomolgus öpum https://tlh.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://tlh.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17671558392865792.html Einn- Til Multi-Hólf PK módel útskýrð|NHP lyfjahvörf|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://tlh.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17671557760410624.html Hvernig á að velja áreiðanlegan forklínískan CRO|Lykilviðmið fyrir líftæknifyrirtæki|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://tlh.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17671557737161728.html Þýðing CAR-T mat: In Vitro sérfræðiþekking og NHP rannsóknarstuðningur — Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://tlh.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17671557825668096.html Af hverju mistakast meira en 90% lyfjaframbjóðenda í miðtaugakerfi í klínískum rannsóknum? https://tlh.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://tlh.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17671557970813952.html Forklínísk líkön fyrir Parkinsonsveiki: Leiðbeiningar um val á taugaeitrun, erfðafræðilegum og NHP líkönum|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://tlh.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17671558024225792.html Há-nákvæm lyfjaafhending og gervigreind-drifnir NHP þýðingarkerfi https://tlh.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://tlh.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17660653365257216.html Th17-drifin NHP ónæmisfræðilíkön|Þýðingarrannsóknir á sjálfsofnæmi hjá Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://tlh.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17660653392765952.html AI-undirstaða NHP BehaviorAtlas® System|3D atferlisgreiningarvettvangur|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://tlh.prisysbiotech.com/news/rfp-template-for-nhp-studies-17660653356803072.html RFP sniðmát fyrir NHP rannsóknir|Flýttu forklínískri rannsóknarhagkvæmni https://tlh.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://tlh.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17660653166781440.html Cold Allodynia Pain Model í Cynomolgus Monkeys|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://tlh.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17660653524018176.html MRI-Leiðbeinandi lyfjaafhendingarvettvangur í heila|Prisys líftækni miðtaugakerfisrannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://tlh.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17660653578331136.html NHP öndunarfærasjúkdómalíkön og lyfjaafhendingarvettvangur í öndunarvegi|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://tlh.prisysbiotech.com/news/nhp-renal-biopsy-17660653505340416.html NHP nýrnavefjarannsóknarvettvangur og nýrnasjúkdómalíkön|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251022172158e338d.jpg https://tlh.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17660653387719680.html PK rannsóknir og markviss fíkniefnasending|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://tlh.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17660653288104960.html NHP Research and AI-Based Behavioral Analysis Platform Prisys Biotechnologies https://tlh.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://tlh.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17660653125526528.html Nef-til-heila (N2B) afhendingartækni fyrir miðtaugarannsóknir|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://tlh.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17660653032432640.html SHR-2004: Bylting í forvörnum gegn bláæðasegareki fyrir sjúklinga með krabbamein í eggjastokkum – Árangurssaga eftir Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://tlh.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537910958531584.html Cynomolgus & Rhesus apamódel|Prisys líftækni forklínískt cro https://tlh.prisysbiotech.com/uploads/39406/news/n202509191421539fa9b.jpg https://tlh.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530069227234304.html Idiopathic lungnabólga (IPF) NHP líkan|Prisys líftækni forklínískt cro https://tlh.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://tlh.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530069375411200.html Cynomolgus apa lífdreifingarrannsóknir|Prisys líftækni forklínískt cro https://tlh.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://tlh.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530069437981696.html Prisys líftækni NHP líkön fyrir blóðmeinafræði og heilablóðfallsrannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://tlh.prisysbiotech.com/news/the-importance-of-administration-volume-17530069123359744.html Mikilvægi hljóðstyrks í forklínískum rannsóknum|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://tlh.prisysbiotech.com/news/brain-targeted-drug-delivery-17530069266244608.html Brain - markviss lyfjagjöf|Prisys líftækni forklínískar rannsóknir á NHP https://tlh.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://tlh.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530078885733376.html ADC lyfjaþróun|Þýðing PK/PD ramma í forklínískum NHP rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n2025081814020269ffa.jpg https://tlh.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17515590631924736.html NHP verkjalíkön fyrir Discovery Lyfjaþýðingu|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://tlh.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17515591109682176.html Sermi Vs. Plasma: Að velja ákjósanlegan fylki fyrir forklínískan lífgreiningu https://tlh.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://tlh.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17515590824207360.html Forklínískar leiðbeiningar um skammta: IV & PO bindi, pH og osmolarity fyrir nákvæma PK í NHP og öðrum tegundum https://tlh.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://tlh.prisysbiotech.com/news/nhp-copd-model-17515590696166400.html Helstu lungnateppu rannsóknarlíkön og öndunarvettvangur eftir Prisys https://tlh.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://tlh.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17515590517711872.html NHP Bráð blæðingarlíkan: Mikilvægt tæki til að flýta fyrir þróun nýrra blóðfræði lyfja https://tlh.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://tlh.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17515634660959232.html Puritus Research: Prisys Biotech's IL - 31 af völdum NHP líkans til að meta meðferðar gegn lyfjum https://tlh.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://tlh.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17447468371387392.html Leiðbeiningar um mat gegn lyfjum (ADA) https://tlh.prisysbiotech.com/uploads/39406/news/n2025071015011851653.jpg https://tlh.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17447468064056320.html Öndunarmeðferðir: Innbyggður NHP vettvangur Prisys Biotech fyrir forklínískar rannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n202507080951326501f.gif https://tlh.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17447468087190528.html NHP verkjalíkön: Hröðun verkjastillandi lyfjaþróunar hjá Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://tlh.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17447467959903232.html NHP líkanpallar til að styðja við þróun lyfja í flóknum sjúkdómum https://tlh.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://tlh.prisysbiotech.com/news/key-considerations-for-dosing-volume-17447468695708672.html Lykilatriði fyrir skömmtunarrúmmál, pH og mótun í dýralíkönum https://tlh.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://tlh.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17447467986936832.html Verkfræðingar exosomes: Bylting lyfjagjafar vegna kvilla í miðtaugakerfinu - forklínísk innsýn frá Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n20250617131838d8cea.jpg https://tlh.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17447468161639424.html Leiðbeiningar um val á dýrategundum í kjarnsýru eiturefnafræðilegum rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n202506131705069d4cc.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17447467800617984.html Advanced DSA og IMRI PRIOTYS BIOTECH FYRIR Rannsóknir á blóðmyndun, æðum og nýrnasjúkdómum https://tlh.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://tlh.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17447467485963264.html Cynomolgus apaverkir Líkön: Krafandi þýðingarrannsóknir fyrir byltingarkennda jónalækningar https://tlh.prisysbiotech.com/uploads/39406/news/n20250605125053411da.jpg https://tlh.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17447467566113792.html Að efla rannsóknir á ofnæmishúðbólgu: Prisys Biotech's Non-Suman Primate (NHP) líkanið https://tlh.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17447467313636352.html NHP Atopic Dermatitis líkan Prisys líftækni fyrir þróun gegn lyfjum https://tlh.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://tlh.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17380582796420096.html Að hanna dýrarannsóknir: Lykilatriði fyrir forklínískan árangur rannsókna https://tlh.prisysbiotech.com/uploads/39406/news/n2025052317011698995.jpg https://tlh.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17380582404498432.html Ofnæmishúðbólga: Hvernig Cynomolgus apalíkön koma fram nákvæmni lækninga https://tlh.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://tlh.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17380582294823936.html Astmarannsóknir: Hvers vegna frumgerðir sem ekki eru manna eru lykilatriði fyrir nýjar þróun lyfja https://tlh.prisysbiotech.com/uploads/39406/news/n20250512174400b2bec.jpg https://tlh.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17380582280406016.html Að skilja antisense fákirni (ASO) lyfjahvörf: Lykilatriði í frásogi og dreifingu https://tlh.prisysbiotech.com/uploads/39406/news/n202505081658273697e.jpg https://tlh.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17380596295508992.html Rannsóknir á innöndun NHP fyrir líffræði: Sérhæfð forklínísk CRO þjónustu Prisys https://tlh.prisysbiotech.com/uploads/39406/news/n2025043015244899508.jpg https://tlh.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17380582106375168.html Háþróaðar rannsóknir á forklínískum innöndun: Tæknileg getu og sérfræðiþekking hjá Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n202504291646054725d.jpg https://tlh.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17380581898953728.html Að skilja lyfjahvörf (PK): Lykilstærðir og forrit í þróun lyfja https://tlh.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://tlh.prisysbiotech.com/news/intracerebroventricular-icv-injection-17380581862466560.html Innspýting í legslímu (ICV): Nákvæmni miðtaugakerfis fyrir forklínískar rannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://tlh.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17380595310371840.html Innspýting í legi (ICM): Nákvæmni miðun fyrir lækninga miðtaugakerfisins - forklínísk sjónarmið https://tlh.prisysbiotech.com/uploads/39406/news/n202504180938433bda1.jpg https://tlh.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17380581356577792.html Innsprautun (IT) innspýting: Bein miðtaugakerfið fyrir háþróaða meðferð - forklínísk sjónarmið https://tlh.prisysbiotech.com/uploads/39406/news/n202504160948404ad29.jpg https://tlh.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17380581141931008.html Að efla rannsóknir á Parkinsonssjúkdómi með NHP líkaninu https://tlh.prisysbiotech.com/uploads/39406/news/n202504111626379b25c.jpg https://tlh.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17380580917765120.html Forklínískar PK\/PD rannsóknir og NHP líkön fyrir þróun lyfja|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n2025040809451573e94.png https://tlh.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17300317812597760.html Miðun interleukin -31 (IL -31): Skáldsaga í sjálfsnæmissjúkdómi Lyfjaþróun - Prisys Biotech NHP líkön fyrir forklínískar endurgerðir https://tlh.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://tlh.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17292767208334336.html Mat á ónæmisáhrifum á ónæmisáhrifum: Stefna, lykilatriði og val á aðferðum https://img01.v15cdn.com/gallery/4x3/232.webp https://tlh.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17292766748320768.html Örverupróf og áhrif þess á prímata sem ekki eru menn í forklínískum DMPK rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n20250325170337bc1d3.jpg https://tlh.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17292766923531264.html Cynomolgus api legslímuvilla líkan til að efla meðferðarrannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://tlh.prisysbiotech.com/news/membranous-nephropathy-model-17292766719353856.html Advancing Membranous Nefropathy (MN) Lyfjaþróun: Prisys Biotech's Cynomolgus Monkey Model Platform https://img01.v15cdn.com/gallery/4x3/148.webp https://tlh.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17292791303726080.html Lyfjahvörf lyfja til innöndunar: hugmyndafræði breytist frá altækri útsetningu fyrir lungum https://tlh.prisysbiotech.com/uploads/39406/news/n20250310174924e6965.png https://tlh.prisysbiotech.com/news/animal-models-for-womens-health-17292766643053568.html Prisys líftækni: dýralíkön fyrir lækninga kvenna https://tlh.prisysbiotech.com/uploads/39406/news/n202503071009566b10b.png https://tlh.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17292791345046528.html Heims offitudagur|Prisys Biotech NHP Metabicol líkön: knýja þróun næstu kynslóðar meðferðar gegn offitu https://tlh.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://tlh.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17292766617396224.html Prisys líftækni Cynomolgus Monkey Psoriasis líkan: Advancing forklínískt lyfjafræðismat https://tlh.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://tlh.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17292766754726912.html Lífsýni í lifur: Mikilvæg tækni í stórum rannsóknum á lyfjahvörf (PK) fyrir nýja lyfjaþróun https://tlh.prisysbiotech.com/uploads/39406/news/n2025022509490064708.png https://tlh.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17292766520599552.html Sameining lyfjahvörf og lyfhrif í lyfjaþróun https://tlh.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://tlh.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17292766668792832.html Hvað staðfestir sönnun fyrir hugtaki (POC) í lyfjaþróun virkilega? https://tlh.prisysbiotech.com/uploads/39406/news/n20250218092412fb5f5.jpg https://tlh.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17292766361363456.html Dýralíkön|Áskoranir og forrit í þróun verkjalíkans https://tlh.prisysbiotech.com/uploads/39406/news/n202502141328261a025.png https://tlh.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17292767013217280.html Óklínískar lyfjafræðilegar rannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n2025021214305230811.jpg https://tlh.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17252000669164544.html Val á kjörnum ekki mannlegum höfði fyrir eiturefnafræðirannsóknir: Cynomolgus macaque, rhesus macaque og marmoset https://tlh.prisysbiotech.com/uploads/39406/news/n20250205142604591d8.jpg https://tlh.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17292766346109952.html Almennt lupus erythematosus (SLE) og hlutverk dýralíkana í meðferðarþróun https://tlh.prisysbiotech.com/uploads/39406/news/n20250121104603461db.jpg https://tlh.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17292766326940672.html Ómannslegt aðal líkan fyrir iktsýki (RA) https://tlh.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://tlh.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17292766292190208.html Stereotactic hljóðfæri dýraheilans byggð á 3D hnitakerfum https://tlh.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://tlh.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17292791060276224.html Dýralíkön fyrir prófun in vivo (1): Stofnun og flokkun https://tlh.prisysbiotech.com/uploads/39406/news/n20250112202508b936b.jpg https://tlh.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84089429.html Kannar mögulegar leiðir fyrir líffræði til að komast inn í heilann https://tlh.prisysbiotech.com/uploads/39406/news/n202501071034417382f.png https://tlh.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84089430.html Að efla rannsóknir á iktsýki (RA) með prímatlíkönum sem ekki eru mannlegar https://tlh.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://tlh.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84071487.html Að kanna dýralíkön fyrir ofnæmishúðbólgu lyfjaverkun https://tlh.prisysbiotech.com/uploads/39406/news/n202412301624286dab0.jpg https://tlh.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84071483.html Mikilvægt hlutverk dýralíkana í rannsóknum á sjúkdómum manna https://tlh.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://tlh.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84071474.html Parkin genaskortur apalíkan sýnir nýja fyrirkomulag og meðferðarmarkmið fyrir Parkinsonssjúkdóm https://tlh.prisysbiotech.com/uploads/39406/news/n20241224162504c3c54.jpg https://tlh.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84071466.html Leiðbeiningar um óklínískar lyfjaþróun: Bráðar, undirbráðar, undirkrónískar og langvarandi almennar eiturverkanarannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://tlh.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84071471.html Nýstárleg lyfjagjöf frá nefi til heila (N2B): Framhjá blóð-heila hindruninni https://tlh.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://tlh.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84071468.html Tækifæri og áskoranir smásvína sem óklínískrar stórdýrategundar https://tlh.prisysbiotech.com/uploads/39406/news/n2024120911110171c55.jpg https://tlh.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83073889.html Aðferðir til að afhenda lyf fyrir heilasjúkdóma https://tlh.prisysbiotech.com/uploads/39406/news/n202412030944155b417.jpg https://tlh.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83073878.html Rauntíma segulómskoðun innan aðgerða: Stuðningur við samþykki FDA á fyrstu genameðferðinni fyrir AADC skort https://tlh.prisysbiotech.com/uploads/39406/news/n202411280914044b8c7.jpg https://tlh.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83073877.html Rannsóknir á eiturhrifum í augum á augndropum: Lyfjaútsetning og öryggismat https://tlh.prisysbiotech.com/uploads/39406/news/n20241126163322d869c.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82761341.html Prisys Biotech stofnar Cynomolgus Monkey Psoriasis líkan til að flýta fyrir lyfjaþróun https://tlh.prisysbiotech.com/uploads/39406/news/n2024111910582749e02.jpg https://tlh.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82761348.html Alhliða prímatlíkön sem ekki eru mannleg fyrir rannsóknir á nýrnasjúkdómum eftir Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n2024111511090891eb1.jpg https://tlh.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82761342.html Alhliða forklínískt öryggismat á mótefna-lyfjasamböndum (ADC) í non-mannlegum prímötum https://tlh.prisysbiotech.com/uploads/39406/news/n20241111141121c84f3.jpg https://tlh.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82761339.html Lyfjahvörf mat á mótefna-lyfjasamböndum (ADC) í non-mannlegum prímötum https://tlh.prisysbiotech.com/uploads/39406/news/n202411081401283f377.jpg https://tlh.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82761336.html Lyfjafræðileg mat á ADC https://tlh.prisysbiotech.com/uploads/39406/news/n20241106161502bd911.jpg https://tlh.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82761337.html Að skilja DMPK ADC lyfja https://tlh.prisysbiotech.com/uploads/39406/news/n20241029101148c4fbd.jpg https://tlh.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82761466.html Framfarir í þróun kjarnsýrulyfja og rannsóknargetu Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n2024101713330113621.jpg https://tlh.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82268071.html Framfarir í mRNA lungnasendingarkerfum og nýsköpunarþjónustu Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20241014090616a9ff8.jpg https://tlh.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82761340.html Hvers vegna voru 2024 Nóbelsverðlaunin í lífeðlisfræði eða læknisfræði veitt þessum tveimur vísindamönnum sem rannsökuðu MicroRNA? https://tlh.prisysbiotech.com/uploads/39406/news/n20241008113621e90e6.jpg https://tlh.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82761338.html Lyfjahvarfafræðilegar forsendur fyrir lyf í miðtaugakerfi (CNS). https://tlh.prisysbiotech.com/uploads/39406/news/n2024092913295797d3f.jpg https://tlh.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656467.html Framfarir í rannsóknum á miðtaugakerfi: Prisys Biotech er MRI-samhæft heilasprautukerfi og CED tækni https://tlh.prisysbiotech.com/uploads/39406/news/n202408062147375802b.jpg https://tlh.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81209031.html Að efla blæðingar og storknun meðferðarnýjungar með Cynomolgus Monkey MCAO líkani https://tlh.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://tlh.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81209030.html DMPK mat á lyfjum frá miðtaugakerfi (CNS). https://tlh.prisysbiotech.com/uploads/39406/news/n20240924110059a8fdd.png https://tlh.prisysbiotech.com/news/animal-models-of-human-diseases-81209024.html Dýralíkön af sjúkdómum manna https://tlh.prisysbiotech.com/uploads/39406/news/n20240920153353a85bd.png https://tlh.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81209025.html Nýjungar í verkjamati: AI-drifin hegðunargreining https://tlh.prisysbiotech.com/uploads/39406/news/n2024091816220958caa.png https://tlh.prisysbiotech.com/news/china-experimental-monkey-industry-81209022.html Saga, núverandi staða, áskoranir og tækifæri í tilraunaapaiðnaði Kína https://tlh.prisysbiotech.com/uploads/39406/news/n20240909130237c0dc8.jpg https://tlh.prisysbiotech.com/news/human-disease-animal-models-81209023.html Dýralíkön fyrir sjúkdóma manna: mikilvægt tæki til að efla lífeðlisfræðilegar rannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n20240904101437e1414.jpg https://tlh.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81209021.html Mikilvægi forklínískra lyfjahrifa í lyfjaþróun|Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202408281439443e4db.jpg https://tlh.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81209015.html Gjöf í nef í dýrarannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n20240827104336fadf5.png https://tlh.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79419465.html Byltingarkennd miðtaugakerfi lyfjaþróun: PRISYS líftækni kynnir IMRI tækni https://tlh.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://tlh.prisysbiotech.com/news/convection-enhanced-delivery-81209018.html Framfarir nákvæmnislækningar: Convection-Enhanced Delivery (CED) tækni eftir Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n20240822125521f1687.jpg https://tlh.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81209016.html Cynomolgus Monkey Chronic Kidney Disease (CKD) Líkan af Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://tlh.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79545533.html Óklínískt öryggismat á lyfjagjöf í augum með því að nota Cynomolgus Macaques https://tlh.prisysbiotech.com/uploads/39406/news/n2024080116325669291.png https://tlh.prisysbiotech.com/news/compartment-pk-model-81209020.html Að skilja hólf og líkön sem ekki eru hólf í lyfjahvörfum https://tlh.prisysbiotech.com/uploads/39406/news/n202408121135341dcc9.jpg https://tlh.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79545532.html Hlutverk AAV í genameðferð: ónæmissvörun og eiturhrif https://tlh.prisysbiotech.com/uploads/39406/news/n20240801163452493e1.png https://tlh.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81209006.html Háþróuð miðtaugakerfi afhendingartækni í Cynomolgus öpum: flýtir fyrir þróun fákirnislyfja https://tlh.prisysbiotech.com/uploads/39406/news/n20240809165539b61ef.jpg https://tlh.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79545534.html Bjartsýni óklínísk ónæmingargeta matsaðferðir https://tlh.prisysbiotech.com/uploads/39406/news/n2024080116353273f4d.png https://tlh.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79545531.html Að draga úr notkun ómannlegra prímata í óklínískum öryggismati: sjónarhorn frá FDA og iðnaði https://tlh.prisysbiotech.com/uploads/39406/news/n20240801163624dabc0.png https://tlh.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79545583.html LCMS forklínísk lífgreining á LNP-undirstaða genameðferðarlyfjum https://tlh.prisysbiotech.com/uploads/39406/news/n20240801181230b6a27.jpg https://tlh.prisysbiotech.com/news/mrna-based-therapies-past-79545580.html MRNA-undirstaða meðferðir: Fortíð https://tlh.prisysbiotech.com/uploads/39406/news/n2024080118112364d2d.jpg https://tlh.prisysbiotech.com/news/pk-strategies-of-pdc-79545527.html Aðferðir við lyfjahvarfarannsóknir á peptíð-lyfjasamböndum (PDC) https://tlh.prisysbiotech.com/uploads/39406/news/n2024080109123097cb8.png https://tlh.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79545576.html Lyfhrifafræðileg (PD) mat á genameðferð https://tlh.prisysbiotech.com/uploads/39406/news/n20240801180623d1663.jpg https://tlh.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79545574.html Lyfjahvörf og lífgreining á fákirnislyfjum-(1) https://tlh.prisysbiotech.com/uploads/39406/news/n20240801180452c5c2a.jpg https://tlh.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79545578.html Lyfjahvörf og lífgreining á fákirnislyfjum: Frásog og lyfjahvörf í plasma (PK) einkenni https://tlh.prisysbiotech.com/uploads/39406/news/n20240801180317bc744.jpg https://tlh.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79545577.html Þættir sem þarf að hafa í huga fyrir ónæmingargetu fákirnislyfja https://tlh.prisysbiotech.com/uploads/39406/news/n202408011801502cfb9.jpg https://tlh.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79545579.html MRNA: Öflugt og fjölhæft tæki til að berjast gegn sjúkdómum-Prisys-Líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202408011756272a013.jpg https://tlh.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79545575.html Kínverskir vísindamenn bjóða upp á nýjar aðferðir til að snúa við kjarnaeinkennum Parkinsons sjúkdóms https://tlh.prisysbiotech.com/uploads/39406/news/n20240801175516ecb8a.jpg https://tlh.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79545571.html Prisys líftækni: Nýjar lípíð nanóagnir fyrir MRNA afhendingu í prímötum https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117542971a31.jpg https://tlh.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79545572.html Mikilvægi þýðingarannsókna frá grunnrannsóknum til klínískra rannsókna https://tlh.prisysbiotech.com/uploads/39406/news/n20240801175156b8ed0.jpg https://tlh.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79545562.html Helstu þættir sem teknir eru til greina í WOE greiningu https://tlh.prisysbiotech.com/uploads/39406/news/n20240801175020842f8.jpg https://tlh.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79545561.html Hvernig á að skila líffræðilegum efnum til heilans? https://tlh.prisysbiotech.com/uploads/39406/news/n20240801174910a58bb.jpg https://tlh.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79545559.html Hvernig lyf hreyfast og breytast í líkama okkar: Stutt kynning á lyfjahvörfum https://tlh.prisysbiotech.com/uploads/39406/news/n202408011748076fca9.jpg https://tlh.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79545558.html Hvernig á að þróa ný lyf hraðar og öruggara: Leiðbeiningar um forklínískar DMPK rannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117445005c7b.jpg https://tlh.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79545560.html Leiðbeiningar um hóphúsnæði fyrir rannsóknarstofuapa https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117440822f67.jpg https://tlh.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79545555.html Mikilvægt hlutverk tilraunaapa við að efla vísindarannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n20240801174211d2a1b.jpg https://tlh.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79545557.html Að skilja Macaca Fascicularis (Cynomolgus Monkey): Helstu eiginleikar og framlag til líflæknisfræðilegra rannsókna https://tlh.prisysbiotech.com/uploads/39406/news/n20240801174043f9c14.jpg https://tlh.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79545554.html Byltingarkennd efnaskiptasjúkdómameðferð: Framfarir og áskoranir í þróun peptíðlyfja https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117395084c9b.jpg https://tlh.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79545552.html Hvernig á að meta öryggi húðvara fyrir klínískar prófanir? https://tlh.prisysbiotech.com/uploads/39406/news/n20240801173853b9e8e.jpg https://tlh.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79545556.html Mikilvægur þáttur tilraunaapa í nýstárlegri lyfjaþróun: innsýn í fyrirtækið https://tlh.prisysbiotech.com/uploads/39406/news/n20240801173640dbcdb.jpg https://tlh.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79545553.html Eituráhrif á lifur sem lykiláhyggjuefni fyrir SiRNA lyf: Alhliða greining á marksérhæfni: Tvíeggjað sverð SiRNA https://tlh.prisysbiotech.com/uploads/39406/news/n20240801173252513ea.jpg https://tlh.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79545551.html Að efla SiRNA meðferð: Að sigrast á áskorunum í lyfjaþróun https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117311060b15.jpg https://tlh.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79545550.html Notkunarhorfur á genalyfjum sem byggjast á lípíð nanóögnum https://tlh.prisysbiotech.com/uploads/39406/news/n20240801172808b0a45.jpg https://tlh.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79545548.html Lykilatriði í hönnun aðferða fyrir ekki-klínískar rannsóknir á ungum dýrum https://tlh.prisysbiotech.com/uploads/39406/news/n20240801172702f375a.jpg https://tlh.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79545547.html Innsýn í skyn- og hegðunareiginleika prímata sem ekki eru mannlegar (NHPs) https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117261321519.jpg https://tlh.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79545545.html Óklínískt námsmat Spurt og svarað https://tlh.prisysbiotech.com/uploads/39406/news/n20240801172429e1895.jpg https://tlh.prisysbiotech.com/news/significance-principles-and-requirements-of-79545546.html Mikilvægi, meginreglur og kröfur um öryggi lyfjafræðirannsókna https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117231644f61.jpg https://tlh.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79545543.html Hvernig á að meta forklíníska lyfjafræðilega verkun? https://tlh.prisysbiotech.com/uploads/39406/news/n20240801172217a2b22.jpg https://tlh.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79545542.html Hugleiðingar um óklínískar lyfjafræðirannsóknir og mat á lækningalyfjum við óáfengri lifrarbólgu (NASH) https://tlh.prisysbiotech.com/uploads/39406/news/n202408011720005c93e.jpg https://tlh.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79545538.html Efling miðtaugakerfis og CGT rannsóknir: Prisys líftækni leiðir veginn https://tlh.prisysbiotech.com/uploads/39406/news/n202408011718404c246.jpg https://tlh.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79545539.html Leiðbeiningar um söfnun heila- og mænuvökva sem ekki eru mannlegir prímatar https://tlh.prisysbiotech.com/uploads/39406/news/n20240801171318f7961.jpg https://tlh.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79545540.html Athugasemdir við að túlka klínískar meinafræðigögn í non-mannlegum prímötum (NHP) og vígtönnum https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117122736428.jpg https://tlh.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79545530.html Að samþætta öryggismat á miðtaugakerfi í almennar eiturefnafræðirannsóknir https://tlh.prisysbiotech.com/uploads/39406/news/n2024080117110558056.jpg https://tlh.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79545535.html Hvernig á að framkvæma forklíníska lyfjafræði/eiturefnafræðilega mat á ADC? https://tlh.prisysbiotech.com/uploads/39406/news/n20240801170828e5c98.jpg https://tlh.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79545537.html ADME innsýn fyrir fákirnislyf (1) - Frásog, dreifing https://tlh.prisysbiotech.com/uploads/39406/news/n202408011705192b402.jpg https://tlh.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79545536.html ADME Innsýn fyrir fákirnislyf (2) - Umbrot og útskilnaður https://tlh.prisysbiotech.com/uploads/39406/news/n20240801164818e22a4.jpg https://tlh.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79545528.html Forklínískar dýrarannsóknir (1) - Dýrategundir https://tlh.prisysbiotech.com/uploads/39406/news/n202408011646162c426.jpg https://tlh.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79545529.html Túlkun gagna í klínískri meinafræði Áskoranir og aðferðir í forklínískum rannsóknum á hundum og prímötum sem ekki eru úr mönnum https://tlh.prisysbiotech.com/uploads/39406/news/n20240801164503e9bd9.jpg https://tlh.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79545541.html Forklínískar dýrarannsóknir (2) - Lyfjaleiðir og magn lyfjagjafar https://tlh.prisysbiotech.com/uploads/39406/news/n20240801163712d0df1.jpg https://tlh.prisysbiotech.com/news/mrna-based-therapies-present-79545582.html MRNA-undirstaða meðferðir: Núverandi https://tlh.prisysbiotech.com/uploads/39406/news/n2024080118104113739.jpg https://tlh.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79545585.html MRNA-undirstaða meðferðir: framtíð og áskoranir https://tlh.prisysbiotech.com/uploads/39406/news/n2024080118092133eb2.jpg https://tlh.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79545573.html Stutt kynning um líffræðilega greiningu á genameðferð https://tlh.prisysbiotech.com/uploads/39406/news/n202408011807079dc4e.jpg https://tlh.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79419464.html Cynomolgus Monkey í augnlyfjarannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n2024072509180742b12.png https://tlh.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79419466.html Þýðingar- og krossviðbragðsrannsóknir með NHP-líkönum Prisys um ónæmisfræði og bólgu https://tlh.prisysbiotech.com/uploads/39406/news/n2024072212200879ff1.png https://tlh.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79192433.html NHPs sem ekki eru barnalegir í forklínískum rannsóknum: Hagkvæm lausn eftir Prisys Biotech https://tlh.prisysbiotech.com/uploads/39406/news/n2024071618013071b40.png https://tlh.prisysbiotech.com/news/nhp-asthma-model-79192431.html NHP astmalíkan: efla forklínískar lyfjaáhrifarannsóknir með Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n202407051359254acc6.png https://tlh.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79192432.html Efling ónæmisfræði og bólgurannsókna með Cynomolgus Macaques módelum - Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20240703110911ef80e.png https://tlh.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79192430.html Bein sending fákjarnalyfja í miðtaugakerfið og algengar vefjameinafræðilegar breytingar https://tlh.prisysbiotech.com/uploads/39406/news/n202406131052303d31d.png https://tlh.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79192429.html Heilaæðaslag (ICH) líkan af Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n20240607164926587f9.png https://tlh.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75182797.html Óklínískar lyfjafræðilegar rannsóknir: mikilvægur þáttur í þróun SiRNA lyfja https://tlh.prisysbiotech.com/uploads/39406/news/n202402211320123fe5b.jpg https://tlh.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77716915.html MRI-stýrt miðtaugakerfi stórdýra Nákvæm staðsetning og sendingakerfi sest í Prisys líftækni https://tlh.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://tlh.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77063765.html Nýstárlegar lausnir til að efla öndunarmeðferðir https://tlh.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://tlh.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74860266.html Prisys: Að efla dýratilraunir með Cynomolgus Macaque rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n202402271423376ec81.png https://tlh.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76211964.html Prisys nær fullri viðurkenningu frá AAALAC International: Tímamót í því að tryggja háar kröfur um umönnun tilraunadýra. https://img01.v15cdn.com/gallery/4x3/265.webp https://tlh.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74741909.html Auka kjarnsýrumeðferð með nýjustu með Prisys Biotech Nonhuman prímatlíkönum https://tlh.prisysbiotech.com/uploads/39406/news/n202401261332041ba3c.jpg https://tlh.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74173426.html Byltingarkennd lyfjagjöf í miðtaugakerfi: Prisys og loforð um inndælingu í mænuvökva https://tlh.prisysbiotech.com/uploads/39406/news/n20240111101138bd6a1.jpg https://tlh.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75182798.html Prisys Biotech 2024 Fréttabréf 1. ársfjórðungs - áreiðanlegur sérfræðingur þinn í NonHuman Primate rannsóknum https://tlh.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://tlh.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73539922.html Hvernig ómskoðun leiðsögn lifur vefjasýni eykur Macaque-undirstaða rannsóknir https://tlh.prisysbiotech.com/uploads/202339406/n202312211047254501881.jpg https://tlh.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73536101.html Leiðbeiningar um lífstíðarnotkun prímata sem ekki eru mannlegar í lífeðlisfræðilegum rannsóknum: Líftæknisjónarmið Prisys https://tlh.prisysbiotech.com/uploads/39406/news/n202402271428388db72.png https://tlh.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73013014.html Prímatar sem ekki eru menn: Stutt kynning á líffræðilegum eiginleikum þeirra https://tlh.prisysbiotech.com/uploads/39406/news/n202402271431193773d.png https://tlh.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72680472.html Umsögn um sýninguna|Prisys Biotech skín á ársfundi American Society for Neuroscience (SfN 2023) https://tlh.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://tlh.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72324940.html Hittu Prisys Biotech á ársfundi Society For Neuroscience (SfN 2023) https://tlh.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://tlh.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72324942.html Alþjóðlegur heilablóðfallsdagur|Áhersla á blóðþurrðarheilkenni dýralíkön og lyfjafræði https://tlh.prisysbiotech.com/uploads/202339406/n202310292017544133660.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72324939.html Prisys Biotech býður þér að mæta á ársfund SAPA-Kína árið 2023 https://tlh.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://tlh.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72324943.html Alþjóðlegur Alzheimerdagurinn|Áskoranir og lausnir fyrir AD lyfjaþróun https://tlh.prisysbiotech.com/uploads/202339406/n202309211504565472671.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72324937.html Cynomolgus Macaque dýralíkan Prisys Biotech hjálpar við þróun nýrra segavarnarlyfja https://tlh.prisysbiotech.com/uploads/202339406/n202309182207050266461.png https://tlh.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71000221.html Prisys: Veitir hágæða dýratilraunaþjónustu fyrir hið nýja mótefni gegn storkuþætti XI BJTJ-1837 https://tlh.prisysbiotech.com/uploads/202339406/n202308311332528401166.jpg https://tlh.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71000220.html Aðferð til að koma á Cynomolgus Monkey líkani af háþríglýseríðhækkun og notkun þess https://tlh.prisysbiotech.com/uploads/202339406/n202308212156285814136.jpg https://tlh.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71006678.html Lyfjafræði: Helstu breytur og mikilvægi lyfjahvarfa (PK) https://tlh.prisysbiotech.com/uploads/202339406/n202308091145033318894.jpg https://tlh.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71000219.html Forklínísk lyfjafræði mat á krabbameinslyfjum https://tlh.prisysbiotech.com/uploads/202339406/n202308071041585027430.jpg https://tlh.prisysbiotech.com/news/0-71000223.html Hvernig lítil kjarnsýrulyf geta umbreytt meðferð á miðtaugakerfissjúkdómum: Innsýn frá Prisys líftækni, leiðandi CRO-veitanda NHP-sjúkdómalíkana https://tlh.prisysbiotech.com/uploads/202339406/n202308041018581481730.jpg https://tlh.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71000222.html Lyfjahvörf, rannsóknaraðferðir og tilviksrannsóknir á peptíðlyfjum https://tlh.prisysbiotech.com/uploads/202339406/n202308031715493686411.jpg https://tlh.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69692398.html Helstu rannsóknarpunktar ADC Drug PK https://tlh.prisysbiotech.com/uploads/202339406/n202307302137108622628.jpg https://tlh.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69707048.html Prisys Líftækni: Leiðtogi í NHP CNS Disease Modeling Research Platform https://tlh.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://tlh.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69310428.html Hvernig á að léttast og stjórna sykursýki með GLP-1 vörum https://tlh.prisysbiotech.com/uploads/202339406/n202307162139405018976.jpg https://tlh.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69310425.html Hvernig China Monkey hjálpar til við að framkvæma forklínískar rannsóknir skilvirkni? https://tlh.prisysbiotech.com/uploads/39406/news/n20240227143532bd79a.png https://tlh.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69310424.html Hver er skilvirkni RNAi? https://tlh.prisysbiotech.com/uploads/202339406/n202307092210201669077.jpg https://tlh.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69310426.html Prisys Biotech Stórdýratilraun Almannaþjónustuvettvangur: Lágverðs og hagkvæm lausn fyrir stórdýratilraunir https://tlh.prisysbiotech.com/uploads/39406/news/n2024022714394317bcf.png https://tlh.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69065894.html Hvernig AAV genameðferð getur bjargað sýn þinni: Nýjustu byltingarnar úr frumrannsóknum sem ekki eru mannlegar https://tlh.prisysbiotech.com/uploads/202339406/n202307022231508642715.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69065892.html Prisys Biotech sýnir vettvang fyrir ómannleg prímatlíkan á ársfundi japanska eiturefnafræðifélagsins https://tlh.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://tlh.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69065895.html Efnileg framtíð AAV genameðferðar hjá prímötum sem ekki eru menn https://tlh.prisysbiotech.com/uploads/202339406/n202306232107539553735.jpg https://tlh.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69065893.html Hvað eru lípíð nanóagnir fyrir genameðferð? https://tlh.prisysbiotech.com/uploads/202339406/n202306182144004132789.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69065891.html Prisys Biotech býður þér að taka þátt í 50. ársfundi japanska eiturefnafræðifélagsins (JSOT) https://tlh.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://tlh.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69065890.html Ónæmiseiturhrifapróf, lyfjaöryggismat-PRISYS BIOTECH https://tlh.prisysbiotech.com/uploads/202339406/n202306102132091628389.jpg https://tlh.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68553530.html Ákjósanlegt dýralíkan af blóðþurrð heilablóðfalli komið á með stafrænni frádrætti, stýrðum eigin blóðsega í Cynomolgus öpum https://tlh.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://tlh.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68277991.html Af hverju þú ættir að vera sama um ómannleg prímöt í rannsóknum og þróun kjarnsýra lyfjagjafarkerfis https://tlh.prisysbiotech.com/uploads/202339406/n202305282122338248983.jpg https://tlh.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68278020.html Hittu Prisys Biotech á 70. JALAS 2023! https://tlh.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://tlh.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68278006.html Genameðferð skín með nýjum samþykki fyrir sjaldgæfum sjúkdómum https://tlh.prisysbiotech.com/uploads/202339406/n202305162133347179081.jpg https://tlh.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68277986.html Byltingarkennd eiturlyfjauppgötvun: Hvernig ómannlegir prímatar hagræða SiRNA skimun fyrir hraðari og skilvirkari niðurstöður https://tlh.prisysbiotech.com/uploads/39406/news/n20240227144111404cb.png https://tlh.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67240741.html Hámarka SiRNA lyfjafræði skilvirkni með rannsóknum á frumatökum sem ekki eru menn https://tlh.prisysbiotech.com/uploads/202339406/n202305022215194112233.jpg https://tlh.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67240740.html Hvernig ómannlegir prímatar geta gjörbylt SiRNA rannsóknum: Alhliða handbók https://tlh.prisysbiotech.com/uploads/202339406/n202304272138362221911.jpg https://tlh.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67240733.html Að fagna alþjóðlegum degi tilraunadýra: hvers vegna Prisys hefur skuldbundið sig til að stuðla að heilbrigði prímata sem ekki eru menn https://tlh.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://tlh.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67240738.html Hámarka CRISPR/Cas9 rannsóknarhagkvæmni með ómannlegum prímatlíkönum https://tlh.prisysbiotech.com/uploads/202339406/n202304221149520486556.jpg https://tlh.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67240734.html Að losa um lækningamöguleikana: hvers vegna fjárfesting í kjarnsýrulyfjum er framtíð læknisfræðinnar https://tlh.prisysbiotech.com/uploads/202339406/n202304200850383332884.jpg https://tlh.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67240739.html Að opna möguleika ómannlegra prímata til að efla genameðferðaruppgötvun lyfjamarkmiða https://tlh.prisysbiotech.com/uploads/202339406/n202304142148160397375.jpg https://tlh.prisysbiotech.com/news/world-parkinsons-disease-day-67240735.html Sameinast fyrir Parkinsonsveiki: Tökum höndum saman til að vekja athygli á alþjóðlegum Parkinsonssjúkdómsdegi https://tlh.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://tlh.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67240736.html Hvernig á að nota non-mannleg prímöt á áhrifaríkan hátt í öryggismati genameðferðar https://tlh.prisysbiotech.com/uploads/202339406/n202304102117431547381.jpg https://tlh.prisysbiotech.com/news/gene-therapy-toxicology-66268694.html Genameðferð eiturefnarannsóknir með Nonhuam Primate https://tlh.prisysbiotech.com/uploads/202339406/n202304052050241172289.jpg https://tlh.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66149099.html Alhliða leiðarvísir til að framkvæma DMPK rannsókn fyrir genameðferð https://tlh.prisysbiotech.com/uploads/202339406/n202303292053463875854.jpg https://tlh.prisysbiotech.com/news/gene-therapy-nhp-model-66151947.html Byltingarkennd læknisrannsóknir: Bylting í genameðferð í líkönum af ómannlegum prímatsjúkdómum! https://tlh.prisysbiotech.com/uploads/202339406/n202303282057377312705.jpg https://tlh.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66149098.html Topp 10 vinsælar spurningar sem tengjast genameðferð https://tlh.prisysbiotech.com/uploads/202339406/n202303241229248740600.jpg https://tlh.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66149097.html Prisys líftækni: Lyfjafræði sem ekki er mannleg prímat fyrir genameðferð https://tlh.prisysbiotech.com/uploads/202339406/n202303241128310077112.jpg https://tlh.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66149096.html Stuðningur við heilsu kvenna: innsýn í legslímuvillu https://tlh.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://tlh.prisysbiotech.com/news/prisys-sot2023-66149095.html PRISYS og Taichu Group eru í samstarfi fyrir SOT sýninguna árið 2023 https://tlh.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://tlh.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66149093.html Þurfum við frekari rannsóknir fyrir verkjamat? - NHP https://tlh.prisysbiotech.com/uploads/202339406/n202303081329477852711.jpg https://tlh.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66149094.html Taktu þátt í að fagna alþjóðlegum degi dýralífsins https://tlh.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://tlh.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66149091.html Prisys Shanghai NHP R&D Center opnar og markar tímamót í lyfjarannsóknum og þróun í Kína https://tlh.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://tlh.prisysbiotech.com/news/meetprisys-sot2023-66149090.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://tlh.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg